Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Workload-induced changes to cell state contribute to β-cell failure in diabetes.

bioRxiv : the preprint server for biology·2026
Same author

Engineered vasculature induces functional maturation of pluripotent stem cell-derived islet organoids.

Developmental cell·2025
Same author

Effectiveness of myofascial therapy (MFT) along with traditional physiotherapy and intermittent prophylaxis on short-term improvement of joint health in hemophilic arthropathy: a randomized control trial.

Expert review of hematology·2025
Same author

Canadian Association of Radiologists Cancer Diagnostic Imaging Referral Guideline.

Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes·2025
Same author

5-Formylcytosine is an activating epigenetic mark for RNA Pol III during zygotic reprogramming.

Cell·2024
Same author

Systematic rare variant analyses identify RAB32 as a susceptibility gene for familial Parkinson's disease.

Nature genetics·2024
Same journal

Continuous Glucose Monitoring Metrics and Perinatal Outcomes in Pregnant Women with Type 2 Diabetes.

Diabetes technology & therapeutics·2026
Same journal

Invited Commentary: Using Large Clinical Databases.

Diabetes technology & therapeutics·2026
Same journal

Impact of Technology Introduction on Glycemic Control of People Living with Type 1 Diabetes in Belgium: An Observational, Real-World Study.

Diabetes technology & therapeutics·2026
Same journal

Differences in Achieving Stringent Glycemic Targets Among Youth with Type 1 Diabetes: A SWEET Registry Study.

Diabetes technology & therapeutics·2026
Same journal

<i>Letter:</i> "Nocturnal Hypoglycemia: Characterization with Continuous Glucose Monitoring in a Real-World Setting".

Diabetes technology & therapeutics·2026
Same journal

Transient Benign Ketosis Is Common in Type 1 Diabetes During Very-Low Carbohydrate States: Novel Data from Continuous Ketone Sensor.

Diabetes technology & therapeutics·2026
See all related articles

Related Experiment Videos

Java-based diabetes type 2 prediction tool for better diagnosis.

Shankaracharya1, Devang Odedra, Medhavi Mallick

  • 1Department of Biotechnology, Birla Institute of Technology, Mesra, Ranchi, India. shankaracharya@bitmesra.ac.in

Diabetes Technology & Therapeutics
|November 9, 2011
PubMed
Summary
This summary is machine-generated.

This study developed a neural network model for diabetes diagnosis, achieving 97% accuracy. A user-friendly interface allows physicians to input patient data for quick and reliable type 2 diabetes predictions.

Related Experiment Videos

Area of Science:

  • Computational intelligence
  • Machine learning in healthcare

Background:

  • Diabetes diagnosis is a critical challenge, often hindered by the complexity of clinical data interpretation.
  • Existing neural network classification methods show promise but lack patient accessibility.
  • There is a need for user-friendly tools to facilitate early diabetes detection.

Purpose of the Study:

  • To develop an accurate and accessible diagnostic tool for type 2 diabetes.
  • To leverage computational intelligence for improved diabetes prediction.
  • To create a system that assists medical practitioners in patient diagnosis.

Main Methods:

  • A neural network mixture of experts model was employed.
  • The model was trained using the expectation-maximization algorithm on a dataset of 768 individuals from the Pima Indian population.
  • A graphical user interface was developed for intuitive data input and output.

Main Results:

  • The mixture of experts model achieved a diagnostic accuracy of 97%.
  • The developed graphical user interface effectively presents the prediction results.
  • The system provides instant diabetes predictions with a high degree of confidence.

Conclusions:

  • The study presents a machine-implementable approach for minimizing diagnostic errors in diabetes.
  • The developed tool empowers physicians to quickly diagnose type 2 diabetes by entering patient health profiles.
  • Further research replicating these findings in diverse populations could enhance diagnostic capabilities globally.